The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

BACKGROUND. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of amiodarone discontinuation in CF-LVAD patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Chinnadurai, Thiru, Patel, Snehal R., Saeed, Omar, Hanif, Waqas, Rivas-Lasarte, Mercedes, Farooq, Muhammad, Castillo, Carolyne, Taveras, Maria, Fauvel, Daphenie, Shin, Jooyoung J., Sims, Daniel, Murthy, Sandhya, Vukelic, Sasha, Chavez, Patricia, Forest, Stephen, Goldstein, Daniel, Jorde, Ulrich P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Heart Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759622/
https://www.ncbi.nlm.nih.gov/pubmed/35047663
http://dx.doi.org/10.1097/TXD.0000000000001281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759622/
https://www.ncbi.nlm.nih.gov/pubmed/35047663
http://dx.doi.org/10.1097/TXD.0000000000001281

Ejemplares similares